Notice2022-05753
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 18, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Generic Clearance for Lyme and other Tickborne Diseases (TBD) Knowledge, Attitudes, and Practices (KAP) Surveys. This data collection involves the administration of a set of surveys designed to understand KAPs related to prevention of Lyme and other TBDs and to inform implementation of future TBD prevention interventions.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 53 (Friday, March 18, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 53 (Friday, March 18, 2022)]
[Notices]
[Pages 15433-15435]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-05753]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-1150; Docket No. CDC-2022-0035]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed and/or
continuing information collection, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on a proposed
information collection project titled Generic Clearance for Lyme and
other Tickborne Diseases (TBD) Knowledge, Attitudes, and Practices
(KAP) Surveys. This data collection involves the administration of a
set of surveys designed to understand KAPs related to prevention of
Lyme and other TBDs and to inform implementation of future TBD
prevention interventions.
DATES: CDC must receive written comments on or before May 17, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0035 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://Regulations.gov">Regulations.gov</a>. Follow the
instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS
[[Page 15434]]
H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email: <a href="/cdn-cgi/l/email-protection#107f7d72507374733e777f66"><span class="__cf_email__" data-cfemail="36595b547655525518515940">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Generic Clearance for Lyme and other Tickborne Diseases (TBD)
Knowledge, Attitudes, and Practices (KAP) Surveys (OMB Control No.
0920-1150, Exp. 9/30/2022)--Revision--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and Prevention (CDC) Division of
Vector-Borne Diseases (DVBD) and other programs working on tickborne
diseases (TBDs) are requesting a Revision to a previously approved
generic clearance to conduct TBD prevention studies to include
knowledge, attitudes, and practices (KAP) surveys TBDs among residents
and businesses offering pest control services in Lyme disease endemic
areas of the United States. The data collection for which approval is
sought will allow DVBD to use survey results to inform implementation
of future TBD prevention interventions. The Revision involves a
broadening of the secondary target population from owners and employees
of pest control companies to stakeholders of local entities affected by
TBDs (e.g., leaders in local public health or local government; owners
or employees of pest control companies, landscaping companies, or other
at-risk occupations; non-governmental organizations serving at-risk
populations; and/or clinicians serving at-risk populations).
TBDs are a substantial and growing public health problem in the
United States. From 2004-2016, over 490,000 cases of TBDs were reported
to CDC, including cases of anaplasmosis, babesiosis, ehrlichiosis, Lyme
disease, Rocky Mountain spotted fever, and tularemia. Lyme disease
accounted for 82% of all TBDs, with over 400,000 cases reported during
this time period. Recent studies estimate nearly 500,000 cases of Lyme
disease are diagnosed annually in the United States. In addition,
several novel tickborne pathogens have recently been found to cause
human disease in the United States. Factors driving the emergence of
TBDs are not well defined and current prevention methods have been
insufficient to curb the increase in cases. Data is lacking on how
often certain prevention measures are used by individuals at risk as
well as what the barriers to using certain prevention measure are.
The primary target population for these data collections are
individuals and their household members who are at risk for TBDs
associated with I.scapularis ticks and who may be exposed to these
ticks residentially, recreationally, and/or occupationally. The
secondary target population includes stakeholders of local entities
affected by TBDs (e.g., leaders in local public health or local
government; owners or employees of pest control companies, landscaping
companies, or other at-risk occupations; non-governmental organizations
serving at-risk populations; and/or clinicians serving at-risk
populations) in areas where I. scapularis ticks transmit diseases to
humans. Specifically, these target populations include those residing
or working in the 15 highest incidence states for Lyme disease (CT, DE,
ME, MD, MA, MN, NH, NJ, NY, PA, RI, VT, VA, WI and WV). We anticipate
conducting one to two surveys per year, for a maximum of six surveys
conducted over a three-year period. Depending on the survey, we aim to
enroll 500-10,000 participants per study. It is expected that we will
need to target recruitment to about twice as many people as we intend
to enroll. Surveys may be conducted daily, weekly, monthly, or bi-
monthly per participant for a defined period (whether by phone or web
survey), depending on the survey or study. The surveys will range in
duration from approximately 5-30 minutes. Each participant may be
surveyed 1-64 times in one year; this variance is due to differences in
the type of information collected for a given survey. Specific burden
estimates for each study and each information collection instrument
will be provided with each individual project submission for OMB
review.
Insights gained from KAP surveys will aid in prioritizing which
prevention methods should be evaluated in future randomized, controlled
trials and ultimately help target promotion of proven prevention
methods that could yield substantial reductions in TBD incidence. CDC
requests OMB approval for an estimated 98,830 annual burden hours.
There is no cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
General public, individuals or Screening 20,000 1 15/60 5,000
households. instrument.
Consent form.... 10,000 1 20/60 3,330
Introductory 10,000 1 30/60 5,000
Surveys.
[[Page 15435]]
Monthly surveys. 10,000 12 15/60 30,000
Final surveys... 10,000 1 30/60 5,000
Daily surveys... 10,000 60 10/60 50,000
Stakeholders of local entities Stakeholder 1,000 1 30/60 500
affected by TBDs. Survey.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 98,830
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-05753 Filed 3-17-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 18, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.